HF
NXL icon

HRT Financial’s Nexalin Technology NXL Stock Holding History

HRT Financial’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8K Buy
+23,453
New +$12.2K ﹤0.01% 3649

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $1.87B AUM 29.51% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HRT Financial's NXL Position: Q1 2026 in Review

HRT Financial opened a new position in Nexalin Technology (NXL) in Q1 2026: 23,453 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #3649 among its holdings.

23 funds tracked by Wall St. Rank hold NXL as of Q1 2026.

  • HRT Financial held 23,453 shares of Nexalin Technology worth $8K as of Q1 2026.
  • Nexalin Technology was a new HRT Financial position in Q1 2026.
  • Nexalin Technology made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3649 holding.
  • 23 funds tracked by Wall St. Rank held Nexalin Technology as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.